Skip to main content

Neurofibromatosis

  • Chapter
  • First Online:
Genetic Counseling for Adult Neurogenetic Disease
  • 1359 Accesses

Abstract

Neurofibromatosis 1 (NF1) is one of the most common inherited neurologic diseases. NF1 is due to autosomal dominant mutations in the Nf1 gene; fifty percent of cases have de novo mutations. Mutations appear to be fully penetrant with intra- and inter-familial variability. Genetic counseling can be complicated by the possibility of mosaicism. People with NF1 often experience shame about their own condition and guilt of passing on the disorder. Genetic counseling should address the psychosocial aspects of the disease as well as the physical.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Borofsky, S., & Levy, L. M. (2013). Neurofibromatosis: Types 1 and 2. American Journal of Neuroradiology, 13(4), 1071–1077. http://dx.doi.org/10.3174/ajnr.A3534.

  2. Boyd, K. P., Korf, B. R., & Theos, A. (2009). Neurofibromatosis type 1. Journal of the American Academy of Dermatology, 61(1), 1–14.

    Article  PubMed Central  PubMed  Google Scholar 

  3. Ferner, R. E., Huson, S. M., Thomas, N., Moss, C., Willshaw, H., Evans, D. G., et al. (2006). Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. Journal of Medical Genetics, 44(2), 81–88.

    Article  PubMed Central  PubMed  Google Scholar 

  4. Vranceanu, A. M., Merker, V. L., Park, E., & Plotkin, S. R. (2013). Quality of life among adult patients with neurofibromatosis 1, neurofibromatosis 2 and schwannomatosis: A systematic review of the literature. Journal of Neuro-Oncology, 114, 257–262. doi:10.1007/s11060-013-1195-2.

    Article  PubMed  Google Scholar 

  5. Uhlmann, E. J., & Plotkin, S. R. (2012). Neurofibromatoses. In S. Ahmad (Ed.), Neurodegenerative diseases (pp. 266–277). New York, NY: Spring Science Business Media.

    Chapter  Google Scholar 

  6. Piotrowski, A., Xie, J., Liu, Y. F., Poplawski, A. B., Gomes, A. R., Madanecki, P., et al. (2014). Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas. Nature Genetics, 46, 182.

    Article  PubMed  Google Scholar 

  7. Brems, H., Pasmant, E., Van Minkelen, R., Wimmer, K., Upadhyaya, M., Legius, E., et al. (2012). Review and update of SPRED1 mutations causing Legius syndrome. Human Mutation, 33(11), 1538–1546.

    Article  PubMed  Google Scholar 

  8. Patil, S., & Chamberlain, R. S. (2012). Neoplasms associated with germline and somatic NF1 gene mutations. The Oncologist, 17(1), 101–116.

    Article  PubMed Central  PubMed  Google Scholar 

  9. Leppig, K. A., Kaplan, P., Viskochil, D., Weaver, M., Ortenberg, J., & Stephens, K. (1997). Familial neurofibromatosis 1 microdeletions: Cosegregation with distinct facial phenotype and early onset of cutaneous neurofibromata. American Journal of Medical Genetics, 73(2), 197–204.

    Article  PubMed  Google Scholar 

  10. Pasmant, E., Vidaud, M., Vidaud, D., & Wolkenstein, P. (2012). Neurofibromatosis type 1: From genotype to phenotype. Journal of Medical Genetics, 49(8), 483–489.

    Article  PubMed  Google Scholar 

  11. Moles, K. J., Gowans, G. C., Gedela, S., Beversdorf, D., Yu, A., Seaver, A. H., et al. (2012). NF1 microduplications: Identification of seven nonrelated individuals provides further characterization of the phenotype. Genetics in Medicine, 14(5), 508–514.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Amanda Bergner .

Editor information

Editors and Affiliations

1 Electronic Supplementary Material

Below is the link to the electronic supplementary material.

Neurofibromatosis 1 (NF1) Part 1 (MOV 373,086 kb)

Neurofibromatosis 1 (NF1) Part 2 (MOV 297,172 kb)

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Bergner, A. (2015). Neurofibromatosis. In: Goldman, J. (eds) Genetic Counseling for Adult Neurogenetic Disease. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-7482-2_23

Download citation

Publish with us

Policies and ethics